Thanks M, this explains a lot.
Negatives
I was hoping the Melbourne plant was one of the smaller ones, but it looks like it is the biggest.
6m stock - smaller than I expected
Positives
They have filled the last big order (small orders?) so can concentrate on new orders.
China's production will be for internal or LDC's
India is probably the next one to be given a licence. Once again probably for domestic markets or LDC's
Countries are unlikely to break patent.
- Forums
- ASX - By Stock
- BTA
- glaxosmithkline update: influenza a (h1n1)
glaxosmithkline update: influenza a (h1n1), page-2
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online